Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-Small Cell Lung Cancer

This study has been terminated.
(The protocol has been completed prematurely due to slow accrual and budget issues.)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01342770
First received: April 23, 2011
Last updated: July 9, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)